Russian invasion of Ukraine could have multimillion-dollar impact on Novo Nordisk

1 percent of Novo Nordisk’s total sales could potentially be impacted by the war in Ukraine, said Novo exec Maziar Mike Doustdar at the company’s capital markets day.
Maziar Mike Doustdar, EVP of international operations at Novo Nordisk | Photo: Novo Nordisk / PR
Maziar Mike Doustdar, EVP of international operations at Novo Nordisk | Photo: Novo Nordisk / PR
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen

It’s not yet fully known what Russia’s invasion of neighboring country Ukraine will mean for Denmark’s biggest pharmaceutical firm, Novo Nordisk.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading